SD, IL-13 Production Rate in IPF

Status:
Completed

Trial end date:
2009-06-01

Target enrollment:

Participant gender:

The purpose of this study is to investigate how QAX576 affects levels of interleukin 13 (IL-13) in patients with idiopathic pulmonary fibrosis (IPF).

Phase 2

Novartis Pharmaceuticals